Switch theme
Sign up to access all valuation multiples
Sikarin PCL is a Thailand-based company operating in the healthcare sector. It operates private hospitals located in eastern Bangkok, Samutprakarn Province and Hat Yai District, Songkhla Province namely Sikarin Hospital, Sikarin Samut Prakan Hospital, and Sikarin Hat Yai Hospital. Its services include general surgery services, obstetrics, aesthetic center, dental center, orthopedic center, checkup center, emergency and trauma center, and children center, among others.
1994
3.0K+
Last FY Revenue $185M
Last FY EBITDA $43.5M
$395M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Sikarin achieved revenue of $185M and an EBITDA of $43.5M.
Sikarin expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Sikarin valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $185M | XXX | XXX | XXX |
| Gross Profit | XXX | $53.7M | XXX | XXX | XXX |
| Gross Margin | XXX | 29% | XXX | XXX | XXX |
| EBITDA | XXX | $43.5M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 24% | XXX | XXX | XXX |
| EBIT | XXX | $25.4M | XXX | XXX | XXX |
| EBIT Margin | XXX | 14% | XXX | XXX | XXX |
| Net Profit | XXX | $20.2M | XXX | XXX | XXX |
| Net Margin | XXX | 11% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Sikarin's stock price is THB 7 (or $0).
Sikarin has current market cap of THB 13.7B (or $416M), and EV of THB 13.0B (or $395M).
See Sikarin trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $395M | $416M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Sikarin has market cap of $416M and EV of $395M.
Sikarin's trades at 2.1x EV/Revenue multiple, and 9.1x EV/EBITDA.
Equity research analysts estimate Sikarin's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Sikarin's P/E ratio is not available.
See valuation multiples for Sikarin and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $416M | XXX | $416M | XXX | XXX | XXX |
| EV (current) | $395M | XXX | $395M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 2.1x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 9.1x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 15.6x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 20.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 14.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSikarin's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $10K for the same period.
Sikarin's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Sikarin's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Sikarin and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 24% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $10K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 15% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sikarin acquired XXX companies to date.
Last acquisition by Sikarin was XXXXXXXX, XXXXX XXXXX XXXXXX . Sikarin acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Sikarin founded? | Sikarin was founded in 1994. |
| Where is Sikarin headquartered? | Sikarin is headquartered in Thailand. |
| How many employees does Sikarin have? | As of today, Sikarin has 3.0K+ employees. |
| Is Sikarin publicy listed? | Yes, Sikarin is a public company listed on BKK. |
| What is the stock symbol of Sikarin? | Sikarin trades under SKR ticker. |
| When did Sikarin go public? | Sikarin went public in 1988. |
| Who are competitors of Sikarin? | Similar companies to Sikarin include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Sikarin? | Sikarin's current market cap is $416M |
| Is Sikarin profitable? | Yes, Sikarin is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
